Hims & Hers Health, Inc.
- Jurisdiction
United States - LEI
549300ZQ4ZUYSAAX6P59 - ISIN
US4330001060 (HIMS )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€19.43 156.8% overvalued - Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
5
/ 7
Profile
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. Read full profile
Fundamentals
- Net revenue
€1.72B - Gross margin
76.2% - EBIT
€107.12M - EBIT margin
6.2% - Net income
€165.13M - Net margin
9.6%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
| Name | Title | Transaction Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Okupe Oluyemi | Chief Financial Officer |
|
|
|
|
| Boughton Soleil | Chief Legal Officer |
|
|
|
|
| Dudum Andrew | Chief Executive Officer |
|
|
|
|
| Okupe Oluyemi | Chief Financial Officer |
|
|
|
|
| Boughton Soleil | Chief Legal Officer |
|
|
|
|
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Lisa McClain | September 12, 2025 | $1.00K–$15.00K |
Earnings Calls
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Peter Brown |
|
|
|
Buy |
| Ray Dalio |
|
|
|
Buy |
Earnings Calls
Latest earnings call: November 6, 2023 (Q3 2023)